GF12712610
Aluminum
sphere, 100pcs, diameter 6.0mm, 99%
Synonym(s):
Aluminum, AL006860
Sign Into View Organizational & Contract Pricing
All Photos(2)
About This Item
Recommended Products
Assay
99%
form
spheres
autoignition temp.
1400 °F
manufacturer/tradename
Goodfellow 127-126-10
resistivity
2.6548 μΩ-cm
particle size
6.0 mm
bp
2460 °C (lit.)
mp
660.37 °C (lit.)
density
2.7 g/mL at 25 °C (lit.)
SMILES string
[Al]
InChI
1S/Al
InChI key
XAGFODPZIPBFFR-UHFFFAOYSA-N
Related Categories
General description
For updated SDS information please visit www.goodfellow.com.
Legal Information
Product of Goodfellow
Storage Class Code
13 - Non Combustible Solids
WGK
WGK 3
Flash Point(F)
Not applicable
Flash Point(C)
Not applicable
Certificates of Analysis (COA)
Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Plant science : an international journal of experimental plant biology, 185-186, 1-8 (2012-02-14)
Al inhibits root apex elongation with concomitant morphological injuries such as ruptures punctuated by the regions stained with Evans blue. The recovery can be investigated by transfer of Al-injured roots to a solution lacking Al. In the Al-injured root apex
Journal of inorganic biochemistry, 105(11), 1513-1517 (2011-11-22)
Aluminum (Al) has been implicated in a variety of neurological diseases. However, the molecular mechanisms that enable Al to be involved in these disorders have yet to be fully delineated. Using astrocytes as a model of the cerebral cellular system
Journal of Alzheimer's disease : JAD, 35(1), 7-43 (2013-02-06)
The neuroanatomic specificity with which Alzheimer's disease (AD) progresses could provide clues to AD etiopathology. Magnetic resonance imaging studies of AD clinical progression have confirmed general conclusions from earlier studies of AD neuropathological progression wherein neurofibrillary tangle pathology was observed
Journal of inorganic biochemistry, 105(11), 1505-1512 (2011-11-22)
In 1991, treatment with low dose intramuscular desferrioxamine (DFO), a trivalent chelator that can remove excessive iron and/or aluminum from the body, was reported to slow the progression of Alzheimer's disease (AD) by a factor of two. Twenty years later
Current medicinal chemistry, 19(17), 2773-2793 (2012-03-30)
This review is focused on recent developments on hydroxypyri(mi)dines, as aluminum and actinide chelating agents to combat the toxicity due to accumulations of these metal ions in human body resulting from excessive metal exposure. After a brief update revision of
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service